These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8325126)

  • 1. Enterococcus faecalis: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against high-level-gentamicin-resistant isolates.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1993; 39(4):248-53. PubMed ID: 8325126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Hayden MK; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1986; 32(3):270-85. PubMed ID: 3086051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin against Streptococcus faecalis.
    Chen HY; Williams JD
    Eur J Clin Microbiol; 1984 Oct; 3(5):436-8. PubMed ID: 6238822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis.
    Lefort A; Baptista M; Fantin B; Depardieu F; Arthur M; Carbon C; Courvalin P
    Antimicrob Agents Chemother; 1999 Mar; 43(3):476-82. PubMed ID: 10049254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teicoplanin combined with various antibiotics and human blood against a multiple-drug-resistant strain of Staphylococcus aureus.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1991; 37(3):186-95. PubMed ID: 1832374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
    Schick DG; Canawati HN; Montgomerie JZ
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):233-9. PubMed ID: 9458980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level gentamicin-resistant enterococci: in vitro activity of double and triple combinations of antimicrobial drugs.
    Ferrara A; Dos Santos C; Cimbro M
    Chemotherapy; 1996; 42(1):37-46. PubMed ID: 8751265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Messick CR; Woodward J; Pendland SL
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of high-level, gentamicin-resistant enterococci isolated from bacteremic patients.
    Wiland AM; Plaisance KI; Schwalbe RS
    Pharmacotherapy; 1994; 14(1):89-94. PubMed ID: 8159604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterococcus faecium: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against multiple-antibiotic-resistant strains.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1993; 39(4):254-64. PubMed ID: 8325127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy.
    Kowalski RP; Karenchak LM; Warren BB; Eller AW
    Ophthalmic Surg Lasers; 1998 Apr; 29(4):295-9. PubMed ID: 9571661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolated from artisanal food of animal origin in Argentina.
    Delpech G; Pourcel G; Schell C; De Luca M; Basualdo J; Bernstein J; Grenovero S; Sparo M
    Foodborne Pathog Dis; 2012 Oct; 9(10):939-44. PubMed ID: 22953740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of periodontal Enterococcus faecalis.
    Rams TE; Feik D; Mortensen JE; Degener JE; van Winkelhoff AJ
    J Periodontol; 2013 Jul; 84(7):1026-33. PubMed ID: 23106507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis.
    Pérez JL; Riera L; Valls F; Berrocal CI; Berrocal L
    J Antimicrob Chemother; 1987 Sep; 20(3):357-62. PubMed ID: 3119551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug resistance of 100 clinical strains of Enterococcus spp].
    Sawicka-Grzelak A; Rokosz A; Luczak M
    Med Dosw Mikrobiol; 1999; 51(3-4):239-47. PubMed ID: 10803253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M; Perichon B; Lefort A; Carbon C; Courvalin P; Fantin B
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.
    Itokazu GS; Nathan C; Hariharan R; Kostman JR; Kabins SA; Weinstein RA
    Chemotherapy; 1996; 42(4):235-9. PubMed ID: 8804789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.